Using time-restricted eating to help cancer survivors with fatigue
Time-restricted eating to address cancer-related fatigue among survivors of hematological malignancies
This study is looking at whether eating all your meals within a 10-hour window each day can help reduce tiredness in people who have survived blood cancers, and it’s designed for those who want to feel more energetic after their treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10978430 on NIH RePORTER |
What this research studies
This research investigates how time-restricted eating, where participants consume food within a specific 10-hour window each day, can help alleviate cancer-related fatigue in survivors of blood cancers. The study will involve a 12-week randomized controlled trial comparing the effects of this eating pattern against a control group that does not restrict their eating times. Participants will be monitored for changes in fatigue levels and metabolic health, with follow-up assessments planned for 24 weeks. The goal is to understand if aligning eating patterns with natural circadian rhythms can improve the well-being of cancer survivors.
Who could benefit from this research
Good fit: Ideal candidates for this research are blood cancer survivors who are 2 months to 2 years post-curative treatment and experience moderate to severe fatigue.
Not a fit: Patients who are not survivors of blood cancers or those who do not experience significant fatigue may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a novel, non-pharmacological approach to reduce fatigue in cancer survivors, enhancing their quality of life.
How similar studies have performed: Previous research has shown promising results with time-restricted eating in other populations, suggesting potential benefits for cancer survivors, although this specific application is relatively novel.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Kleckner, Amber Simmons — University of Maryland Baltimore
- Study coordinator: Kleckner, Amber Simmons
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.